XML 40 R26.htm IDEA: XBRL DOCUMENT v3.25.0.1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Schedule of Restrictions on Cash and Cash Equivalents The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
December 31,
2024		December 31,
2023
Cash and cash equivalents$240 $204 
Restricted cash6 98 
Cash, cash equivalents and restricted cash$246 $302 
Schedule of Cash and Cash Equivalents The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
December 31,
2024		December 31,
2023
Cash and cash equivalents$240 $204 
Restricted cash6 98 
Cash, cash equivalents and restricted cash$246 $302 
Schedule of Shares Used in Computing Basic and Diluted Earnings Per Share Shares used in computing basic and diluted earnings per share are as follows: 
Three Months Ended
December 31,
 20242023
Denominator (thousands of shares):
Weighted-average common shares outstanding — basic214,933 209,782 
Incremental shares issuable for stock options, common stock awards, UGI Corporation Senior Notes, and Equity Units (a)(b)762 5,788 
Weighted-average common shares outstanding — diluted215,695 215,570 
(a)For the three months ended December 31, 2024 and 2023, there were 7,792 and 8,285 shares, respectively, associated with outstanding stock option awards that were not included in the computation of diluted earnings per share above because their effect was antidilutive.
(b)The Equity Units were settled in June 2024. See Note 13 in the Company’s 2024 Annual Report for additional information on the Equity Units.